Skip to main content
Top
Published in: Chinese Medicine 1/2010

Open Access 01-12-2010 | Research

Quality assurance for Chinese herbal formulae: standardization of IBS-20, a 20-herb preparation

Authors: Siu-Po Ip, Ming Zhao, Yanfang Xian, Mengli Chen, Yuying Zong, Yung-Wui Tjong, Sam-Hip Tsai, Joseph JY Sung, Alan Bensoussan, Brian Berman, Harry HS Fong, Chun-Tao Che

Published in: Chinese Medicine | Issue 1/2010

Login to get access

Abstract

Background

The employment of well characterized test samples prepared from authenticated, high quality medicinal plant materials is key to reproducible herbal research. The present study aims to demonstrate a quality assurance program covering the acquisition, botanical validation, chemical standardization and good manufacturing practices (GMP) production of IBS-20, a 20-herb Chinese herbal formula under study as a potential agent for the treatment of irritable bowel syndrome.

Methods

Purity and contaminant tests for the presence of toxic metals, pesticide residues, mycotoxins and microorganisms were performed. Qualitative chemical fingerprint analysis and quantitation of marker compounds of the herbs, as well as that of the IBS-20 formula was carried out with high-performance liquid chromatography (HPLC). Extraction and manufacture of the 20-herb formula were carried out under GMP. Chemical standardization was performed with liquid chromatography-mass spectrometry (LC-MS) analysis. Stability of the formula was monitored with HPLC in real time.

Results

Quality component herbs, purchased from a GMP supplier were botanically and chemically authenticated and quantitative HPLC profiles (fingerprints) of each component herb and of the composite formula were established. An aqueous extract of the mixture of the 20 herbs was prepared and formulated into IBS-20, which was chemically standardized by LC-MS, with 20 chemical compounds serving as reference markers. The stability of the formula was monitored and shown to be stable at room temperature.

Conclusion

A quality assurance program has been developed for the preparation of a standardized 20-herb formulation for use in the clinical studies for the treatment of irritable bowel syndrome (IBS). The procedures developed in the present study will serve as a protocol for other poly-herbal Chinese medicine studies.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fong HHS, Pauli GF, Bolton JL, van Breemen RB, Banuvar S, Shulman L, Geller SE, Farnsworth NR: Evidence-based herbal medicine: Challenges in efficacy and safety assessments. Annals of Traditional Chinese Medicine, Current Review of Chinese Medicine. Edited by: Leung PC, Fong H, Xue CC. 2006, Singapore: World Scientific, 2: 11-26. full_text.CrossRef Fong HHS, Pauli GF, Bolton JL, van Breemen RB, Banuvar S, Shulman L, Geller SE, Farnsworth NR: Evidence-based herbal medicine: Challenges in efficacy and safety assessments. Annals of Traditional Chinese Medicine, Current Review of Chinese Medicine. Edited by: Leung PC, Fong H, Xue CC. 2006, Singapore: World Scientific, 2: 11-26. full_text.CrossRef
2.
go back to reference Tang JL, Zhan SY, Ernst E: Review of randomized controlled trials of traditional Chinese medicine. Br Med J. 1999, 319: 160-161.CrossRef Tang JL, Zhan SY, Ernst E: Review of randomized controlled trials of traditional Chinese medicine. Br Med J. 1999, 319: 160-161.CrossRef
3.
go back to reference Barrett M: Identifying and characterizing botanical products. The Handbook of Clinically Tested Herbal Remedies. Edited by: Barrett M. 2004, New York: The Haworth Herbal Press, 1: 23-36. Barrett M: Identifying and characterizing botanical products. The Handbook of Clinically Tested Herbal Remedies. Edited by: Barrett M. 2004, New York: The Haworth Herbal Press, 1: 23-36.
4.
go back to reference Brinker F: Managing and interpreting the complexities of botanical research. Herbal Gram. 2009, 82: 42-49. Brinker F: Managing and interpreting the complexities of botanical research. Herbal Gram. 2009, 82: 42-49.
5.
go back to reference Chadwick L, Fong HHS: Herb quality assurance and standardization in herb-drug interaction evaluation and documentation. Herbal Supplement - Drug Interactions. Edited by: Lam YWF, Huang SM, Hall SD. 2006, New York: Taylor & Francis, 191-203.CrossRef Chadwick L, Fong HHS: Herb quality assurance and standardization in herb-drug interaction evaluation and documentation. Herbal Supplement - Drug Interactions. Edited by: Lam YWF, Huang SM, Hall SD. 2006, New York: Taylor & Francis, 191-203.CrossRef
6.
go back to reference Ernst E: Methodological aspects of traditional Chinese medicine (TCM). Ann Acad Med Singapore. 2006, 35: 773-774.PubMed Ernst E: Methodological aspects of traditional Chinese medicine (TCM). Ann Acad Med Singapore. 2006, 35: 773-774.PubMed
7.
go back to reference Tyler VE: Product definition deficiencies in clinical studies of herbal medicines. The Handbook of Clinically Tested Herbal Remedies. Edited by: Barrett M. 2004, New York: The Haworth Herbal Press, 1: 13-22. Tyler VE: Product definition deficiencies in clinical studies of herbal medicines. The Handbook of Clinically Tested Herbal Remedies. Edited by: Barrett M. 2004, New York: The Haworth Herbal Press, 1: 13-22.
8.
go back to reference Kearney DJ, Brown-Chang J: Complementary and alternative medicine for IBS in adults: mind-body interventions. Nat Clin Pract Gastroenterol Hepatol. 2008, 5 (11): 624-636. 10.1038/ncpgasthep1257.CrossRefPubMed Kearney DJ, Brown-Chang J: Complementary and alternative medicine for IBS in adults: mind-body interventions. Nat Clin Pract Gastroenterol Hepatol. 2008, 5 (11): 624-636. 10.1038/ncpgasthep1257.CrossRefPubMed
9.
go back to reference Jailwala J, Imperiale TF, Kroenke K: Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials. Ann Intern Med. 2000, 133 (2): 136-47.CrossRefPubMed Jailwala J, Imperiale TF, Kroenke K: Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials. Ann Intern Med. 2000, 133 (2): 136-47.CrossRefPubMed
10.
go back to reference State Pharmacopoeia Commission of PRC: Pharmacopoeia of the People's Republic of China. Beijing. 2005, 1: State Pharmacopoeia Commission of PRC: Pharmacopoeia of the People's Republic of China. Beijing. 2005, 1:
11.
go back to reference Department of Health, Hong Kong SAR Government: The Hong Kong Chinese Materia Medica Standards. Hong Kong. 2005, I: Department of Health, Hong Kong SAR Government: The Hong Kong Chinese Materia Medica Standards. Hong Kong. 2005, I:
12.
go back to reference Department of Health, Hong Kong SAR Government: The Hong Kong Chinese Materia Medica Standards. Hong Kong. 2008, 2: Department of Health, Hong Kong SAR Government: The Hong Kong Chinese Materia Medica Standards. Hong Kong. 2008, 2:
13.
go back to reference Department of Health, Hong Kong SAR Government: The Hong Kong Chinese Materia Medica Standards. Volume 3. Hong Kong. Department of Health, Hong Kong SAR Government: The Hong Kong Chinese Materia Medica Standards. Volume 3. Hong Kong.
14.
go back to reference World Health Organization: Quality Control Methods for Medicinal Plant Materials. Geneva. 1998 World Health Organization: Quality Control Methods for Medicinal Plant Materials. Geneva. 1998
15.
go back to reference Ip SP, Che CT: Determination of aflatoxins in Chinese medicinal herbs by high-performance liquid chromatography using immunoaffinity column cleanup Improvement of recovery. J Chromatogr A. 2006, 1135 (2): 241-244. 10.1016/j.chroma.2006.10.025.CrossRefPubMed Ip SP, Che CT: Determination of aflatoxins in Chinese medicinal herbs by high-performance liquid chromatography using immunoaffinity column cleanup Improvement of recovery. J Chromatogr A. 2006, 1135 (2): 241-244. 10.1016/j.chroma.2006.10.025.CrossRefPubMed
16.
go back to reference Chan SSK, Zhao M, Lao L, Fong HHS, Che CT: Magnolol and honokiol account for the anti-spasmodic effect of Magnolia officinalis in isolated guinea pig ileum. Planta Med. 2008, 74 (4): 381-384. 10.1055/s-2008-1034320.CrossRefPubMed Chan SSK, Zhao M, Lao L, Fong HHS, Che CT: Magnolol and honokiol account for the anti-spasmodic effect of Magnolia officinalis in isolated guinea pig ileum. Planta Med. 2008, 74 (4): 381-384. 10.1055/s-2008-1034320.CrossRefPubMed
17.
go back to reference Ren L, Xue X, Zhang F, Xu Q, Liang X: High performance liquid chromatography-mass spectrometry analysis of protoberberine alkaloids in medicine herbs. J Sep Sci. 2007, 30 (6): 833-842. 10.1002/jssc.200600246.CrossRefPubMed Ren L, Xue X, Zhang F, Xu Q, Liang X: High performance liquid chromatography-mass spectrometry analysis of protoberberine alkaloids in medicine herbs. J Sep Sci. 2007, 30 (6): 833-842. 10.1002/jssc.200600246.CrossRefPubMed
18.
go back to reference Wu W, Song F, Yan C, Liu Z, Liu S: Structural analyses of protoberberine alkaloids in medicine herbs by using ESI-FT-ICR-MS and HPLC-ESI-MS(n). J Pharm Biomed Anal. 2005, 37 (3): 437-446. 10.1016/j.jpba.2004.11.026.CrossRefPubMed Wu W, Song F, Yan C, Liu Z, Liu S: Structural analyses of protoberberine alkaloids in medicine herbs by using ESI-FT-ICR-MS and HPLC-ESI-MS(n). J Pharm Biomed Anal. 2005, 37 (3): 437-446. 10.1016/j.jpba.2004.11.026.CrossRefPubMed
Metadata
Title
Quality assurance for Chinese herbal formulae: standardization of IBS-20, a 20-herb preparation
Authors
Siu-Po Ip
Ming Zhao
Yanfang Xian
Mengli Chen
Yuying Zong
Yung-Wui Tjong
Sam-Hip Tsai
Joseph JY Sung
Alan Bensoussan
Brian Berman
Harry HS Fong
Chun-Tao Che
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Chinese Medicine / Issue 1/2010
Electronic ISSN: 1749-8546
DOI
https://doi.org/10.1186/1749-8546-5-8

Other articles of this Issue 1/2010

Chinese Medicine 1/2010 Go to the issue